Document Detail


Sex-related effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydro-pyridine treatment may be related to differences in monoamine oxidase B.
MedLine Citation:
PMID:  7830954     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Effects of the parkinsonism inducing neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on striatal dopamine metabolism and the influence of sex on the recovery were investigated in adult (2-month-old) male and female C57/BL mice. We present here evidence that MPTP treatment (2 doses of 30 mg/kg i.p., each at 24 h interval) produced a similar reduction (-65% to -70%) of striatal dopamine in both sexes 24 h after the last injection of MPTP, and a greater loss of the metabolites in the female group. In contrast to the partial recovery observed in the male group, an increased dopamine loss occurred in the female group within 10 days following the last injection of MPTP. This impairment in recovery appears to be different to the one already observed in aged (24-month-old) male mice treated in similar conditions. As the neurotoxic effects of MPTP depend on its conversion to the 1-methyl-4-phenylpyridinium ion (MPP+) by monoamine oxidase B (MAO B), the presence of a different peripheral or central MAO B type in female mice could be in part responsible for these sex related effects. To investigate this possibility, MAO A and B activities were characterized in liver and brain of adult female control mice during the different steps of the oestrous cycle and compared to those of adult control male mice. Significant differences in MAO A and MAO B activities could be detected during the oestrous cycle and between the adult male and female groups. It is concluded that MAO B may be involved in the sex related effects of MPTP.
Authors:
M Unzeta; S Baron; V Perez; S Ambrosio; N Mahy
Related Documents :
18793434 - Epigenetic and phenotypic changes result from a continuous pre and post natal dietary e...
23119034 - Impact of age on the cancer-specific survival of patients with localized renal cell car...
22761854 - Differential seroprevalence of human bocavirus species 1-4 in beijing, china.
9308554 - Optimal ratios of topical stratum corneum lipids improve barrier recovery in chronologi...
6721584 - Pulmonary function of exposed and control workers in a nigerian nonsoapy detergent fact...
7056104 - Cardiac arrhythmias in a healthy elderly population: detection by 24-hour ambulatory el...
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Neuroscience letters     Volume:  176     ISSN:  0304-3940     ISO Abbreviation:  Neurosci. Lett.     Publication Date:  1994 Aug 
Date Detail:
Created Date:  1995-02-21     Completed Date:  1995-02-21     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  7600130     Medline TA:  Neurosci Lett     Country:  IRELAND    
Other Details:
Languages:  eng     Pagination:  235-8     Citation Subset:  IM    
Affiliation:
Departamento Bioquímica i Biologia Molecular, Facultad de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine / metabolism,  pharmacology*
1-Methyl-4-phenylpyridinium / metabolism
3,4-Dihydroxyphenylacetic Acid / metabolism
Animals
Dopamine / metabolism
Estrus / physiology
Female
Homovanillic Acid / metabolism
Male
Mice
Mice, Inbred C57BL
Monoamine Oxidase / metabolism*
Neostriatum / enzymology,  metabolism
Sex Characteristics
Chemical
Reg. No./Substance:
102-32-9/3,4-Dihydroxyphenylacetic Acid; 28289-54-5/1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 306-08-1/Homovanillic Acid; 48134-75-4/1-Methyl-4-phenylpyridinium; EC 1.4.3.4/Monoamine Oxidase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Role of the nucleus raphe obscurus in the inhibition of rostral ventrolateral medullary neurones ind...
Next Document:  Sulfhydryl groups essential for the volume-sensitive release of taurine from astrocytes.